Safety Alerts & Recalls

What does this mean?

At this time, there have been no reports of health problems with these recalled Temodar capsules. However, since the recalled capsules did not meet manufacturing standards, you may wish to check your prescription to see if your capsules were involved in the recall. Check your bottle to see if your Temodar capsules are 5 mg and if your bottle is labeled with the lot number 7HLO009. If you think your capsules may be involved in the recall or if you do not know, please return your bottle to your pharmacist to examine and possibly exchange.

If you have any questions or concerns about this recall, please follow up with your doctor or pharmacist. If you think you may be experiencing side effects from your Temodar, please contact your doctor as soon as possible.

Recall on a Single Lot of Temodar Capsules 5 mg

Schering-Plough has recalled a single lot of Temodar (temozolomide) capsules, 5 mg, with the product code NDC 0085-3004-02. Lot number 7HLO009 (Exp 09/10) is being recalled because the capsules did not meet manufacturing standards.

Temodar is used for the treatment of brain cancer. No other strengths of Temodar are involved in this recall.

For more information, please visit: more information here

Source: FDA
Publication Date: 2009-11-12
Last Updated: 2009-12-05

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.